Attached files
file | filename |
---|---|
10-K - BioElectronics Corp | v179172_10k.htm |
EX-99 - BioElectronics Corp | v179172_ex99.htm |
EX-5.2 - BioElectronics Corp | v179172_ex5-2.htm |
EX-5.1 - BioElectronics Corp | v179172_ex5-1.htm |
EX-10.1 - BioElectronics Corp | v179172_ex10-1.htm |
Exhibit
31.1
CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER
Pursuant
to Section 302(a) of the Sarbanes-Oxley Act of 2002
I, Andrew
J. Whelan, certify that:
|
1.
|
I
have reviewed this annual report on Form 10-K of BioElectronics
Corporation;
|
|
2.
|
Based
on my knowledge, this annual report does not contain any untrue statement
of a material fact, or omit to state a material fact necessary to make the
statements made, in light of the circumstances under with such statements
were made, not misleading with respect to the period covered by this
annual report;
|
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this annual report, fairly present in all material respects
the financial condition, results of operations and cash flows of
BioElectronics as of, and for the periods presented in this annual
report;
|
|
4.
|
I
am the sole officer are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e) and
internal controls over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:
|
|
a.
|
designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
b.
|
designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
|
c.
|
evaluated
the effectiveness of the registrant’s disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures as of the end of the period covered
by this report based on such evaluation;
and
|
|
d.
|
disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial
reporting.
|
|
5.
|
I
have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit
committee of the registrant’s board of directors (or persons performing
the equivalent function):
|
|
a.
|
all
significant deficiencies and material weaknesses in the design or
operation of internal controls over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
|
b.
|
any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant’s internal
controls.
|
Date:
March 31, 2010
|
s/ Andrew J. Whelan
|
Andrew
J. Whelan
|
|
President,
CEO and CFO
|
|
(Principal
Executive Officer and Principal Financial
Officer)
|